Projects

Extracorporeal Therapy in Critically Ill Children with Acute Poisoning – Ten-Year Retrospective Study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2026 - 2026

Project Lead

Dr. Saraswathy B

Authors

Dr. Saraswathy B, Dr. Yashaswini K & Dr. Priya Pais

Project Status

ongoing